First of its kind daily HIV treatment shows promising results

Researchers at Queen Mary University of London have led the clinical development of the first non-integrase strand-transfer inhibitor (INSTI) single tablet treatment for HIV, among growing concern for the potential of widespread ...

The new face of HIV in Florida

After four decades of hard-won progress toward curbing the HIV epidemic, the face of the disease is changing.

page 1 from 12